|
|
|
|
|
by acqq
2019 days ago
|
|
The reality is exactly the opposite of what you claim: all the studies of infectiousness of SARS-CoV-2, and even of other respiratory viruses correlate with detection of high virus load in the upper respiratory tract, and don't correlate with the detection of the high virus load in the lower respiratory tract. Here the most recent meta-analysis of the most relevant studies: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5... Your reasoning therefore completely doesn't match the results of many different studies across the world, and also doesn't fit with which people are considered infectious in practice, with all the millions of people involved. So, the study that I've quoted earlier, which detected high viral load in the upper respiratory tract of non-human primate animal model therefore suggests exactly what I've already mentioned that it suggests, namely, that we can not assume that vaccine provides sterilizing immunity unless the later studies with humans show otherwise. And that is exactly how the UK is going to proceed with their vaccination policy, as I've already documented, and also matches the statement of Pfizer's CEO. (I also note that you again try to insinuate that my claims are something that I've never even mentioned, hoping to change the topic. Please don't.) |
|
You're saying:
> "all the studies of infectiousness of SARS-CoV-2, and even of other respiratory viruses correlate with detection of high virus load in the upper respiratory tract"
But, RNA fragments detected by PCR in nasal swabs != live, infectious virus.
The paper you linked is saying, instead:
"Our study shows that despite evidence of prolonged SARS-CoV-2 RNA shedding in respiratory and stool samples, viable virus appears to be short-lived. Therefore, RNA detection cannot be used to infer infectiousness."
"Our findings suggest that, although patients with SARS-CoV-2 infection might have prolonged RNA shedding of up to 83 days in upper respiratory tract infection, no live virus was isolated from culture beyond day 9 of symptoms despite persistently high viral RNA loads."
Residual RNA from lysed cells is sticking around and getting picked up on nasal swabs even when actual, infectious, titers of virus in the body are plummeting, and patients are no longer infectious. I used to work with RNA in a research lab! The shit is everywhere. Our experiments used to get contaminated with RNA from the lab next door all the time. I used to have to spray my bench with a bleach solution every day, sanitize my pipettes, and work at night so my RT-PCR experiments didn't get contaminated. That's in the air. Imagine how long it hangs out in the moist, snotty environment of the nasal cavity.
"Nevertheless, most studies demonstrate faster viral clearance among asymptomatic individuals than those who are symptomatic."
"This finding is in keeping with viral kinetics observed with other respiratory viruses such as influenza and MERS-CoV, in which people with asymptomatic infection have a shorter duration of viral shedding than symptomatic individuals."
Giving these people a vaccine will help them clear the infection even faster, which will help reduce community transmission, especially in places where they're now wandering around without masks on, in full compliance with state law.
I'm happy that the UK is prepared to make aggressive and forward-thinking health policy. Good for the UK, but this ain't the UK. There are a lot of countries like the US where I live, as well as my neighbor Mexico that don't have an NHS, and don't live on a small island with a well-functioning government. These vaccines will help to reduce community transmission in places where the scenes from urban hospitals can best be described as nightmarish.
"No part of the world has been as devastated by the pandemic as Latin America. Mexico, Brazil, Peru and other Latin American countries — hobbled by weak health systems, severe inequality and government indifference — have several of the highest deaths per capita from the virus in the world.
And unlike in Europe, the United States and many other regions, the outbreak in Latin American has not struck in waves. It hit furiously in the spring and has continued for months, with few of the respites savored elsewhere, however briefly, around the world. By the first week of September, the 10 countries with the highest deaths per capita were all in Latin America or the Caribbean."
https://www.nytimes.com/2020/09/23/world/americas/mexico-cor...
Again, shift your frame of reference. The rest of the world does not look like the UK and Europe. Enjoy living somewhere that isn't a charnel house. The vaccines reduce community transmission, and I can say that confidently because I have outlined a pretty clear mechanism for it and there is zero data you have presented that points in the other direction, despite the fact that you keep saying it. Celebrate that fact that we now have this tool in our arsenal.
I promise I'm not the enemy. I promise I'm not conjuring things out of thin air. I'm reading all of the papers you're sending me, and I'm drawing valid scientific insights from them that are applicable to the broader world-at-large, not just the UK with the NHS at the helm, which is able to take steps that for much of the rest of the world is an unrealistic luxury.